Israel Englander Precision Biosciences Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.29 - $0.45 $13,651 - $21,182	-47,073 Reduced 16.76%	233,803 $84,000
Q2 2023 Aug 14, 2023	SELL	$0.52 - $0.91 $1.05 Million - $1.83 Million	-2,013,868 Reduced 87.76%	280,876 $148,000
Q1 2023 May 15, 2023	SELL	$0.7 - $1.41 $759,693 - $1.53 Million	-1,085,277 Reduced 32.11%	2,294,744 $1.73 Million
Q4 2022 Feb 14, 2023	SELL	$0.97 - $45.0 $825,842 - $38.3 Million	-851,384 Reduced 20.12%	3,380,021 $4.02 Million
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $3.29 Million - $110 Million	2,697,179 Added 175.8%	4,231,405 $5.5 Million
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $1.29 Million - $3.74 Million	1,119,435 Added 269.88%	1,534,226 $2.46 Million
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $233,043 - $610,952	-78,731 Reduced 15.95%	414,791 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $1.19 Million - $1.87 Million	160,676 Added 48.27%	493,522 $3.65 Million
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $1.66 Million - $2.55 Million	-180,436 Reduced 35.15%	332,846 $3.84 Million
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $7,125 - $11,055	-883 Reduced 0.17%	513,282 $6.43 Million
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $505,835 - $931,988	-59,024 Reduced 10.3%	514,165 $5.32 Million
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $2.62 Million - $5.45 Million	437,337 Added 321.92%	573,189 $4.78 Million
Q3 2020 Nov 16, 2020	SELL	$4.65 - $8.73 $2.58 Million - $4.83 Million	-553,805 Reduced 80.3%	135,852 $837,000
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $2.45 Million - $4.57 Million	525,678 Added 320.58%	689,657 $5.75 Million
Q1 2020 May 14, 2020	BUY	$5.05 - $15.01 $828,093 - $2.46 Million	163,979 New	163,979 $989,000
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $85,357 - $265,527	-13,506 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.03 - $14.82 $108,453 - $200,158	13,506 New	13,506 $113,000
Q2 2019 Aug 14, 2019	SELL	$11.88 - $16.94 $2.04 Million - $2.91 Million	-171,508 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.44 - $17.95 $2.99 Million - $3.08 Million	171,508 New	171,508 $3.08 Million

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.87 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.17 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$2.04 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.17 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$807,502
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $578M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account